LASIK Eye Surgery Devices Market By Product Type (Femtosecond Lasers, Excimer Lasers and Other Devices), By Application (Myopia, Hyperopia, Astigmatism and Presbyopia), By Technology (Wavefront-Guided LASIK, Wavefront-Optimized LASIK, Topography-Guided LASIK and Others), By End-User (Eye Clinics, Hospitals, Ambulatory Surgical Centers (ASCs), and Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

Report Overview

The LASIK Eye Surgery Devices Market Size is expected to be worth around US$ 2,345.9 million by 2034 from US$ 912.7 million in 2024, growing at a CAGR of 9.9% during the forecast period 2025 to 2034. North America held a dominant market position, capturing more than a 32.5% share and holds US$ 296.6 Million market value for the year.

LASIK eye surgery is the most widely recognized and frequently performed laser refractive procedure to address vision issues. Laser-assisted in situ keratomileusis (LASIK) offers an alternative to glasses or contact lenses. In the LASIK procedure, a specialized cutting laser reshapes the cornea, the clear, dome-shaped tissue at the front of the eye.

The global LASIK eye surgery devices market is experiencing robust growth, driven by advancements in laser technology and increasing demand for vision correction procedures. The market is primarily driven by technological innovations, such as femtosecond and excimer lasers, which improve precision and safety, leading to better patient outcomes.

Additionally, the rising prevalence of refractive errors, such as myopia, hyperopia, and astigmatism, particularly among younger populations, fuels the demand for LASIK surgeries. The growing preference for minimally invasive procedures, offering quick recovery and reduced dependency on corrective eyewear, further supports market expansion. The market is segmented by product types, with femtosecond lasers holding a significant share due to their high precision.

Myopia correction dominates the application segment, while LASIK eye centers are the leading end-users. North America holds the largest market share, supported by advanced healthcare infrastructure and high patient awareness, while Asia-Pacific is expected to experience significant growth due to a large population base and improving healthcare facilities.

As noted by independent sources, data released by MJH Life Sciences in March 2024 indicated that approximately 23% of the global population is currently affected by myopia. Projections suggest that this figure may rise significantly, reaching nearly 50% by the year 2050. In a separate 2024 study conducted by BMJ Publishing Group Ltd., which analyzed data from over 2.2 million children, it was reported that hyperopia was diagnosed in 0.59% of the population surveyed.

Key Takeaways

• In 2024, the market for LASIK Eye Surgery Devices generated a revenue of US$ 912.7 million, with a CAGR of 9.9%, and is expected to reach US$ 2,345.9 million by the year 2034.
• The product type segment is divided into Femtosecond Lasers, Excimer Lasers, and Other Devices with Femtosecond Lasers taking the lead in 2023 with a market share of 52.6%.
• By Application, the market is bifurcated into Myopia, Hyperopia, Astigmatism, and Presbyopia, with Myopia leading the market with 64.5% of market share.
• By Technology, the market is classified into Wavefront-Guided LASIK, Wavefront-Optimized LASIK, Topography-Guided LASIK, and Others, with Wavefront-Guided LASIK taking the lead in 2024 with 32.5% market share.
• Furthermore, concerning the End-User segment, the market is segregated into Eye Clinics, Hospitals, Ambulatory Surgical Centers (ASCs), and Others. The Eye Clinics stands out as the dominant segment, holding the largest revenue share of 44.2% in the LASIK Eye Surgery Devices market.
• North America led the market by securing a market share of 32.5% in 2023.

Product Type Analysis

In the LASIK Eye Surgery Devices Market, femtosecond lasers dominated the product type segment due to their precision and enhanced safety in corneal flap creation and accounted for 52.6% market share. Femtosecond lasers have revolutionized the LASIK procedure by replacing traditional mechanical microkeratomes, which increases the accuracy and reduces the risks of complications. The femtosecond laser is capable of creating a thinner and more uniform corneal flap, which is critical for achieving optimal visual outcomes and minimizing post-surgery issues like dry eye or irregular astigmatism.

An example of a leading femtosecond laser system is the IntraLase FS Laser, which has become a standard in LASIK surgeries worldwide. It allows surgeons to customize the flap depth and thickness with extreme precision, enhancing the procedure’s overall safety and effectiveness. This innovation has driven the adoption of femtosecond lasers in both advanced LASIK centers and general practices, making it the preferred choice among surgeons and patients.

In comparison, excimer lasers are still essential for reshaping the cornea, but the advent of femtosecond lasers has significantly bolstered their use in conjunction with excimer lasers, reinforcing the femtosecond laser’s dominance in the market.

Application Analysis

In the LASIK Eye Surgery Devices Market, myopia (nearsightedness) is the dominant application segment with 64.5% market share due to its higher prevalence among patients seeking refractive surgery. Myopia is a condition where distant objects appear blurry, and it is the most common refractive error worldwide, particularly in younger populations. This has resulted in a substantial demand for LASIK procedures aimed at correcting myopia. LASIK surgeries offer a highly effective solution to correct myopia by reshaping the cornea to allow light to focus properly on the retina.

For example, LASIK devices, particularly excimer and femtosecond lasers, are extensively used to treat myopia, with patients experiencing significant improvements in visual acuity following surgery. As myopia continues to rise, especially due to factors like increased screen time and urbanization, the demand for LASIK surgeries targeting myopia is expected to increase.

Technology Analysis

In the LASIK Eye Surgery Devices Market, Wavefront-Guided LASIK technology dominated with 32.5% market share due to its ability to provide highly customized treatments for patients. This technology uses detailed eye maps to measure the unique imperfections in the eye’s optical system, offering a more personalized approach to vision correction. It can correct not only common refractive errors like myopia, hyperopia, and astigmatism but also higher-order aberrations that affect visual quality, such as glare and halos. As a result, wavefront-guided LASIK often leads to superior post-surgery outcomes, with many patients experiencing clearer, sharper vision compared to traditional LASIK methods.

For example, systems like the VISX Star S4 use wavefront-guided technology to achieve highly precise results, contributing to its widespread adoption in leading LASIK centers. This technology is particularly beneficial for patients with complex vision issues or those who have not had satisfactory results from previous corrective treatments.

End-User Analysis

Eye clinics dominated the end-user segment and accounted for 44.2% market share in 2024 .Due to their specialization in refractive surgeries and high patient volume, eye clinics covers majority of the market share. Eye clinics are dedicated to providing vision correction treatments, including LASIK, which makes them the primary setting for these procedures. They are equipped with the latest LASIK technology and staffed with specialized surgeons who focus on providing personalized care and precision. These clinics offer a more streamlined process for LASIK surgeries, from initial consultation and diagnostics to post-operative care, ensuring better outcomes for patients.

For example, renowned eye care providers such as LasikPlus and Vistakon operate dedicated LASIK centers, attracting large numbers of patients due to their expertise and advanced technology. Hospitals also play a significant role in the market, particularly in regions where LASIK surgery is part of a broader ophthalmology department. However, hospitals tend to offer LASIK as one of many services, which can result in fewer specialized resources compared to eye clinics.

Key Market Segments

By Product Type

• Femtosecond Lasers
• Excimer Lasers
• Other Devices

By Application

• Myopia
• Hyperopia
• Astigmatism
• Presbyopia

By Technology

• Wavefront-Guided LASIK
• Wavefront-Optimized LASIK
• Topography-Guided LASIK
• Others

By End-User

• Eye Clinics
• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Others

Drivers

Technological Advancements in LASIK Devices

Technological innovations in LASIK devices are a major driver of market growth. Femtosecond lasers, excimer lasers, and advancements in diagnostic tools have significantly improved the precision, safety, and effectiveness of LASIK surgeries. These technologies allow for faster procedures, reduced recovery times, and minimal complications.

Furthermore, the introduction of wavefront-guided and topography-guided LASIK has improved the customization of treatments, enhancing outcomes for patients with complex refractive errors. The increased adoption of all-laser LASIK systems, which utilize lasers for both flap creation and corneal reshaping, contributes to the rising demand for these devices. These innovations have transformed LASIK from a traditional procedure into a highly accurate, minimally invasive surgical solution.

In early January 2024, the FDA approved the Teneo Excimer Laser Platform developed by Bausch + Lomb Corporation. This innovative LASIK device provides enhanced vision correction for myopia (nearsightedness) and myopia with astigmatism. Myopia, a common refractive error, causes distant objects to appear blurry while nearby items remain clear. Around 25% of Americans are affected by myopia, which typically develops between the ages of eight and 12 and may worsen during adolescence.

The Teneo excimer laser represents an improvement over previous technologies, offering new and unique features. It is more compact and operates faster than earlier models, making it a valuable addition to the operating room. Teneo also incorporates advanced software that tracks eye movement with a 1740 Hz operating system, ensuring that the patient’s eye movements during LASIK surgery do not interfere with the ablation pattern and results. This software tracking system is three times faster than traditional excimer lasers, allowing for more precise adjustments and improved post-operative LASIK outcomes.

Restraints

High Cost of LASIK Devices

One significant restraint in the LASIK eye surgery devices market is the high cost associated with advanced equipment. Femtosecond lasers and excimer lasers, integral to LASIK surgeries, are expensive to acquire and maintain. These high upfront costs, along with the need for skilled personnel to operate the machines, make LASIK surgeries expensive for both medical practitioners and patients. As a result, the cost can be a deterrent for individuals considering LASIK as an option for vision correction, particularly in developing regions with lower disposable incomes.

While the cost of the technology has decreased over time, it remains a significant barrier for many potential patients who may instead opt for alternative, less expensive treatments. Moreover, the cost burden also affects small clinics and hospitals, preventing them from adopting these advanced technologies, thus limiting the accessibility and growth potential of the LASIK market in certain regions. A clear example of the high cost of LASIK devices and procedures is seen in advanced, all-laser LASIK (bladeless LASIK), which can cost as much as $1,900 per eye in leading Indian metro cities, and up to $2,246 per eye in the United States.

Opportunities

Growing Demand for Vision Correction Procedures

An emerging opportunity in the LASIK eye surgery devices market is the growing demand for vision correction procedures. The increasing global prevalence of refractive errors, such as myopia, hyperopia, and astigmatism, is expected to fuel the demand for LASIK surgeries. Factors such as the rising use of digital devices, which contribute to eye strain and worsen vision, have led to an increasing number of individuals seeking corrective solutions.

Additionally, the growing awareness of LASIK as a safe and effective alternative to traditional corrective measures like glasses and contact lenses is attracting a larger patient base. With the increasing adoption of laser-based vision correction methods, more people, particularly younger adults, are opting for LASIK surgeries. The aging population, with an increasing prevalence of presbyopia, further enhances the potential for LASIK as a long-term vision correction solution.

As the procedure becomes more affordable and accessible, the market is expected to expand further. According to statistics from Marietta Eye Clinic, as of September 2023, over 20,000,000 people have undergone LASIK eye surgery since its introduction. Of these patients, 90% achieve at least 20/20 vision through successful LASIK procedures, with as many as 50% attaining even better vision. Furthermore, patients who do not achieve 20/20 vision still reach 20/40 vision in 99.5% of cases.

Latest Trends

Shift Towards Minimally Invasive LASIK Procedures

A notable trend in the LASIK eye surgery devices market is the increasing preference for minimally invasive procedures. All-laser LASIK systems, which use femtosecond lasers for flap creation and excimer lasers for corneal reshaping, are gaining popularity due to their enhanced precision and reduced risk of complications. These systems eliminate the need for mechanical microkeratomes, making the procedure less invasive and more comfortable for patients.

Additionally, advancements such as wavefront-guided and topography-guided LASIK, which offer personalized treatment plans based on detailed eye mapping, are driving the trend towards more customized and less invasive vision correction. The growing trend towards minimally invasive surgery is driven by patient demand for quicker recovery times, fewer side effects, and more predictable outcomes.

In March 2024, Japan International Eye Hospital was honored to receive the Vietnam SMILE Ambassadors award presented by Carl Zeiss, marking a milestone of 12,500 ReLEx SMILE surgeries successfully performed (counted until September 2023). ReLEx SMILE (Refractive Lenticule Extraction, Small Incision Lenticule Extraction) is a minimally invasive laser eye surgery procedure used to correct vision problems like nearsightedness and astigmatism. It involves creating a small lenticule (a lens-shaped piece of corneal tissue)

Regional Analysis

North America is leading the LASIK Eye Surgery Devices Market

The North American LASIK eye surgery devices market is a leading segment within the global ophthalmic industry holding for over 32.5% market share in 2024, driven by advanced healthcare infrastructure, high patient awareness, and significant technological adoption. This growth is fueled by the increasing prevalence of refractive errors, such as myopia and hyperopia, and a growing preference for minimally invasive procedures.

Technological advancements, including the adoption of femtosecond and excimer lasers, have further enhanced surgical precision and patient outcomes. Additionally, the presence of specialized LASIK centers and ambulatory surgical centers (ASCs) has improved accessibility and affordability, contributing to the market’s expansion. The region’s commitment to research and development ensures continuous innovation, solidifying North America’s position as a leader in the LASIK eye surgery devices market.

In January 2024, the U.S. Food and Drug Administration approved the Teneo Excimer Laser Platform developed by Bausch + Lomb Corporation. This new LASIK technology is designed to treat myopia and myopic astigmatism—commonly known as nearsightedness and nearsightedness with astigmatism. According to an official announcement, the Teneo platform introduces several novel features that had not been available in earlier excimer laser systems, marking a notable advancement in vision correction procedures.

Key Regions and Countries

• North America
  • US
  • Canada
• Europe
  • Germany
  • France
  • The UK
  • Spain
  • Italy
  • Russia
  • Netherland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • New Zealand
  • Singapore
  • Thailand
  • Vietnam
  • Rest of APAC
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of MEA

Key Players Analysis

Key players in the LASIK Eye Surgery Devices market includes Johnson & Johnson Vision, Carl Zeiss Meditec AG, Bausch + Lomb, NIDEK Co., Ltd., Ziemer Ophthalmic Systems AG, SCHWIND eye-tech-solutions GmbH, Lasersight Technologies, Inc., Stryker Corporation, Medtronic, Staar Surgical, and Other key players.

Johnson & Johnson Vision, a subsidiary of Johnson & Johnson, is a global leader in eye care, offering advanced LASIK technologies like the STAR S4 IR Excimer Laser and IntraLase FS femtosecond laser system. The company focuses on improving patient outcomes with innovative vision correction solutions and ocular health products.

Carl Zeiss Meditec AG is a leading German company specializing in ophthalmic and microsurgical technology. Known for its VISUMAX femtosecond laser and MEL 90 excimer laser systems, Zeiss is recognized for providing cutting-edge LASIK devices that ensure high precision and personalized treatments for refractive eye surgeries.

Bausch + Lomb, a major player in eye health, provides a range of products, including excimer and femtosecond lasers for LASIK surgeries. The company’s Technolas series is widely used for its precision in corneal reshaping, contributing to improved visual outcomes in patients seeking vision correction procedures.

Top Key Players in the LASIK Eye Surgery Devices Market

• Alcon
• Johnson & Johnson Vision
• Carl Zeiss Meditec AG
• Bausch + Lomb
• NIDEK Co., Ltd.
• Ziemer Ophthalmic Systems AG
• SCHWIND eye-tech-solutions GmbH
• Lasersight Technologies, Inc.
• Stryker Corporation
• Medtronic
• Staar Surgical
• Other Prominent Players

Recent Developments

• In January 2025: ZEISS Medical Technology received FDA approval for its MEL 90 excimer laser system, marking a significant regulatory milestone. It became the first excimer laser approved in the U.S. for all three key refractive indications—myopia, hyperopia, and mixed astigmatism, the latter requiring simultaneous myopic and hyperopic correction. The MEL 90 is designed to integrate efficiently into the ZEISS Corneal Refractive Workflow and is expected to enhance surgical precision and efficiency for U.S. ophthalmic surgeons. It also complements the previously approved VISUMAX 800 with SMILE pro, thereby expanding ZEISS’s refractive surgery platform and improving patient engagement and outcomes.
• In January 2024: ZEISS Medical Technology obtained FDA approval for the VISUMAX® 800 equipped with SMILE® pro software. This femtosecond laser system was cleared for the surgical correction of nearsightedness, both with and without astigmatism. With over 8 million eyes treated globally using the SMILE technique—particularly across Asia and Europe—this regulatory approval signaled a major step in introducing the next-generation refractive laser technology to the U.S. market.
• In April 2023: Johnson & Johnson Vision announced FDA 510(k) clearance for its ELITA Femtosecond Laser, designed specifically for LASIK flap creation. The company introduced the device during the American Society of Cataract and Refractive Surgery Annual Meeting held in San Diego from May 5–8, 2023. This advancement positioned Johnson & Johnson Vision to further strengthen its presence in the refractive surgery space.

Report Scope